Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

NCT04065906 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Neurofeedback
Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

BEHAVIORAL: NIRS neurofeedback
DRUG: Methylphenidate or Tomoxetine

Sponsor

Xijing Hospital